
News|Articles|March 11, 2024
Measuring Speaker Campaign Effectiveness
Author(s)Pharmagin
Sales and marketing effectiveness of speaker programs is often one of the least understood aspects in the industry. Yet, pharma brands spent over $12.5 billion in 2022 to engage and influence with HCP-to-HCP activities. CMS’s Open Payments data is an overlooked tool to get greater visibility and create more strategic opportunities—while also enriching compliance. This paper explores how to filter and pinpoint critical data sets using browser-based technology to gain marketing insights from this data and measure competitiveness.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Pharmaceutical Executive Daily: Continued Coverage of the 2026 J.P. Morgan Healthcare Conference
2
JP Morgan 2026: Novavax Shifting Towards Partnership-Driven Strategy
3
JP Morgan 2026: AbbVie Advances its Pipeline
4
Making the Transition From Frontline Biopharmaceutical Sales to Wealth Management Advisory
5